Literature DB >> 4162062

Pool's cryoprecipitate and exhausted plasma in the treatment of von Willebrand's disease and factor-XI deficiency.

E Bennett, K Dormandy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4162062     DOI: 10.1016/s0140-6736(66)92985-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III.

Authors:  S Lethagen; E Berntorp; I M Nilsson
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

2.  Surgery in von Willebrand's disease.

Authors:  I M Nilsson; S E Bergentz; S A Larsson
Journal:  Ann Surg       Date:  1979-12       Impact factor: 12.969

3.  The use of blood components in the treatment of congenital coagulation disorders.

Authors:  I M Nilsson; S A Larsson; S E Bergentz
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 4.  Von Willebrand's disease.

Authors:  I M Nilsson; S Lethagen
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

5.  Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.

Authors:  E Bennett; K M Dormandy; W G Churchill; A R Coward; M Smith; T E Cleghorn
Journal:  Br Med J       Date:  1967-04-08

6.  Genetic variants of von Willebrand's disease.

Authors:  L Holmberg; I M Nilsson
Journal:  Br Med J       Date:  1972-08-05

Review 7.  Current management of von Willebrand's disease.

Authors:  G Castaman; F Rodeghiero
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

8.  A retrospective review of cryoprecipitate transfusion practice in Kuala Lumpur Hospital.

Authors:  Intan Iliana Iliassa; Wan Mohd Zahiruddin Wan Mohammad; Jun Jie Tan; Yasmin Ayob
Journal:  Asian J Transfus Sci       Date:  2016 Jul-Dec

9.  In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor.

Authors:  Meaghan E Colling; Kenneth D Friedman; Walter H Dzik
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.